Updated: 27 October 2026 la 00:12. Articolul a fost revizuit pentru a reflecta informațiile disponibile la această dată.
Influenza in Romania, 2026–2027, is beginning to be monitored as respiratory infections rise seasonally, but data from mid-October do not yet indicate an influenza epidemic. The National Institute of Public Health (INSP) reported 81,729 respiratory infections in the week of 12–18 October 2026, including 217 clinically diagnosed influenza cases and only two laboratory-confirmed influenza cases that week. Treating all 81,729 illnesses as influenza would make for an alarming and inaccurate headline.
As of 26 October 2026, the main message is prevention before the virus begins circulating widely: flu vaccination is recommended particularly for people at higher risk, while early symptoms should be assessed according to their severity, age and underlying conditions. This guide explains what INSP measures, the differences between influenza, the common cold, RSV and COVID-19, who qualifies for vaccine reimbursement, when antivirals may be useful, and which signs require urgent medical attention.
For more information on the flu vaccine, see Flu vaccination has begun in Romania: who receives it free of charge in 2026, which provides additional details on the subject.
Editorial update: 26 October 2026. The figures cover epidemiological week 42/2026 (12–18 October), the latest INSP bulletin reviewed for this article. The situation may change weekly; this article does not constitute a diagnosis or advice on self-medication.
Influenza 2026–2027: what Romania’s official data actually show
| INSP indicator | Week of 12–18 October 2026 | How to interpret it |
|---|---|---|
| Reported respiratory infections | 81,729 | The total includes acute upper respiratory tract infections, clinical influenza and pneumonia; not influenza alone |
| Clinical influenza | 217 | Cases classified clinically; not all were confirmed by testing |
| Laboratory-confirmed influenza during the week | 2 | One A(H1) case and one unsubtyped influenza A case |
| SARI cases | 18 | Severe acute respiratory infections reported through surveillance |
| Laboratory-confirmed influenza cases since the start of the season | 15 | Cumulative total to 18 October, rather than week 42 alone |
| Flu vaccinations recorded by 18 October | 400,259 | Doses administered, not a coverage rate for the entire population |
INSP reported a 0.8% decrease in the total number of respiratory infections from the previous week, and 5.8% fewer than in the same week of the previous season. One death confirmed to involve influenza virus had been reported since the start of the season, but none was newly reported in week 42. The figures come from the official INSP bulletin and AGERPRES’s summary of the data.
Across Europe, ECDC’s update of 23 October described influenza activity as still low, while overall respiratory-infection levels were at baseline or low in most participating countries. This picture does not, however, allow an accurate prediction of the month in which the Romanian season will peak.
What do clinical influenza, laboratory confirmation and acute respiratory infection mean?
Clinical influenza is classified on the basis of epidemiological criteria and compatible symptoms, without a specific test being required for every patient. Confirmed influenza means that the virus has been identified through a laboratory method. IACRS refers to acute upper respiratory tract infections, while SARI is a surveillance category for severe acute respiratory infections. These categories serve different purposes; the number of laboratory confirmations does not describe all real infections in the population.
Official sources also matter for historical comparisons: case definitions, reporting by medical practices and testing capacity can affect the numbers. A percentage increase without a denominator or methodology is too little evidence to claim that “influenza is exploding”. For epidemiological interpretation, see the INSP surveillance methodology for the 2026–2027 season.
How does influenza present, and how can it be distinguished from a cold?
Influenza can begin suddenly, with fever or chills, muscle aches, headache, weakness, cough and a sore throat. Not every patient develops a fever, especially older people or those with altered immunity. A common cold often starts more gradually, with a runny nose, sneezing and nasal discomfort, but the symptoms overlap enough that you cannot always reliably distinguish the illnesses by how you feel alone. The CDC describes the clinical picture in its guide to influenza signs.
| Symptom or feature | Influenza | Common cold |
|---|---|---|
| Onset | Often sudden | Usually gradual |
| Fever | Common, but not essential | Less common in adults |
| Muscle aches | May be significant | Usually mild |
| Cough | Common; sometimes severe | Possible, often milder |
| Fatigue | May be pronounced | Usually milder |
| Definitive diagnosis | May require a specific test | May require assessment if the course is atypical |
COVID-19, respiratory syncytial virus (RSV) infection and other viruses can cause similar symptoms. Rapid tests can be useful in selected settings, but sensitivity varies and a negative result does not necessarily rule out infection. Particularly for vulnerable people, a doctor decides whether testing, monitoring or treatment is needed. See also InfoBuz’s analysis of colds, influenza and COVID-19.
Who faces a higher risk of complications?
- People aged over 65, especially those with chronic conditions or frailty.
- Pregnant women and people in the postpartum period, according to clinical assessment.
- Young children, especially those under two, in whom dehydration and respiratory impairment can develop more quickly.
- People with chronic conditions such as lung disease, heart disease, diabetes or immunosuppression.
- Healthcare workers and people caring for vulnerable individuals, because of exposure and the risk of transmission.
Complications can include pneumonia, worsening asthma or other chronic conditions, dehydration and, in severe cases, respiratory failure. Individual risk depends on age, medical history and clinical condition, not solely on a positive test result.
Flu vaccine 2026–2027: who receives it free of charge in Romania
In a statement issued on 2 October 2026, the Ministry of Health recommended priority vaccination for children from six months of age, pregnant women, people over 65, people with chronic conditions, healthcare staff and people living in institutions. Under the applicable legal conditions, high-risk groups receive 100% reimbursement. Adults aged 45 to 65 without chronic conditions receive reimbursement of 50% of the reference price, according to the official statement.
For a vaccine prescription, the Ministry directs patients to their family doctor. The vaccine can be collected from a pharmacy with a prescription and administered at the doctor’s practice or at pharmacies authorised to vaccinate, under the applicable conditions. The injectable flu vaccines in common use cannot cause influenza from the inactivated viruses they contain, although they can cause local reactions, pain or a mild fever. Protection is not immediate and does not guarantee that a vaccinated person will not get influenza at all; it helps reduce the risk of severe illness and complications.
Why the vaccine formulation changes each season
Influenza viruses evolve, and the circulation of subtypes varies from season to season. In February 2026, the World Health Organization recommended components from the A(H1N1)pdm09, A(H3N2) and B/Victoria families for the Northern Hemisphere’s 2026–2027 season, with specific recommended strains depending on the production method. WHO’s recommendation of 27 February 2026 is not a certain prediction of which subtype will actually dominate in Romania.
Depending on age, vaccination history and the authorised product, the number of doses or type of vaccine may differ. Children and people with known medical conditions or allergies should consult a doctor and the leaflet for the available product, rather than automatically applying identical instructions to every brand.
Antivirals, antibiotics and influenza treatment: what is appropriate
For people at higher risk, those who are hospitalised, or those with severe or progressive illness, clinical guidelines recommend prompt assessment for specific antivirals such as oseltamivir, ideally as close as possible to symptom onset. The benefit is often greatest in the first 48 hours; however, treatment may also be indicated after that period in severe cases or for hospitalised patients. This is a medical decision and, for priority groups, it should not necessarily be delayed until a test result is confirmed. See the CDC’s clinical recommendations, updated in March 2026.
Antibiotics do not treat the influenza virus. They may be indicated only when a doctor suspects or confirms a bacterial complication. Symptom treatment generally includes hydration, adequate rest and fever- or pain-relief medicines appropriate to the person’s age and contraindications, as recommended by a doctor or pharmacist. Children should not be given aspirin for suspected influenza because of specific risks. Avoid combining medicines that contain the same active ingredient.
Warning signs: when immediate medical help is needed
- Difficulty breathing, rapid breathing, or bluish lips or face.
- Persistent chest pain or pressure, confusion, fainting, or inability to wake the person normally.
- Significant signs of dehydration: very infrequent urination, lethargy or dry mouth, especially in a child.
- Fever or cough that seems to improve but then returns or worsens significantly.
- In very young infants, fever should be assessed urgently in line with paediatric advice.
For severe or rapidly developing symptoms, call 112. Do not wait for another epidemiological bulletin and do not rely solely on a pulse oximeter, which can produce measurement errors. For symptoms without emergency warning signs, contact a family doctor, especially if the person belongs to a higher-risk group.
Prevention at home, school and work
- Receive seasonal vaccination in line with a doctor’s recommendation and product availability.
- Ventilate enclosed spaces and avoid crowds when you have respiratory symptoms.
- Practise hand hygiene and avoid touching your face with unwashed hands.
- When ill, limit contact with older people and immunocompromised people; a well-fitting mask can reduce transmission.
- Do not send a child with fever and poor general condition to school or childcare; discuss when they can return with a doctor.
- Follow weekly INSP updates, rather than undated viral screenshots.
Frequently asked questions about influenza in 2026–2027
Are all 81,729 respiratory infections influenza cases?
No. INSP’s total includes several categories of respiratory infection. For 12–18 October, it separately reported 217 clinical influenza cases and two laboratory-confirmed cases.
Is there already an influenza epidemic in Romania as of 26 October 2026?
The bulletins reviewed do not confirm an epidemic as of that date. The situation may change in the coming weeks, and official data continue to be checked.
Who receives the flu vaccine free of charge?
The Ministry of Health indicates full reimbursement for the designated higher-risk groups and 50% reimbursement for adults aged 45–65 without chronic conditions, under the programme’s terms. A family doctor can confirm eligibility.
Can I still get influenza if I have been vaccinated?
Yes. Vaccination does not provide absolute protection, but it helps reduce the risk of severe illness and complications.
Prevention in time, without alarmism
As of 26 October 2026, the data point to still relatively low influenza activity, but also the beginning of an important surveillance season. Influenza in 2026–2027 should be understood through the distinction between clinical cases, laboratory confirmations and the total number of viral respiratory illnesses. For vulnerable people, vaccination and early contact with a doctor have real value, while severe warning signs require immediate assistance. This article will need updating when INSP publishes new weekly data.










Discuția cititorilor
Ai o opinie sau o întrebare despre acest articol? Spune-ne ce crezi.
Fii primul care deschide discuția.
Te rugăm să păstrezi un limbaj civilizat și să discuți la subiect. Comentariile spam sunt filtrate automat.